Voyager Therapeutics, Inc. Intellectual Property Contracts & Agreements

7 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Option and License Agreement, by and between Registrant and AstraZeneca Ireland Limited, dated September 30, 2024
License Agreements
Voyager Therapeutics, Inc.
Biotechnology
2024
First Amendment to Option and License Agreement, by and between Registrant and Novartis Pharma AG, dated September 3, 2024
License Agreements
Voyager Therapeutics, Inc.
Biotechnology
2024
Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022
License Agreements
Voyager Therapeutics, Inc.
Biotechnology
DE
2023
Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022
License Agreements
Voyager Therapeutics, Inc.
Biotechnology
DE
2022
Option and License Agreement, by and between the Registrant and Pfizer Inc., dated October 1, 2021
License Agreements
Voyager Therapeutics, Inc.
Biotechnology
DE
2021
First Amendment to Amended and Restated Option and License Agreement with Genzyme Corporation, dated September 20, 2020
License Agreements
Voyager Therapeutics, Inc.
Biotechnology
MA
2020
Amended and Restated Option and License Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019
License Agreements
Voyager Therapeutics, Inc.
Biotechnology
MA
2019